Abstract
Opioid analgesics are used extensively in the management of pain. Although the clinically effective opioids bind with high affinity to the μ-opioid receptor, studies have suggested that the δ-opioid agonists might represent more ideal analgesic agents, with fewer side effects. A limitation to opiate effectiveness is the development of tolerance, an event that has been linked to opioid receptor desensitization. To gain a better understanding of δ-receptor agonist regulation, the cloned mouse δ receptor was stably expressed in human embryonic kidney 293 cells, and the functional effects of agonist pretreatment were examined. With a 3-hr pretreatment protocol, the δ-selective agonists [d-Pen2,d-Pen5]enkephalin, [d-Ala2,d-Leu5]enkephalin, and [d-Ser2,Leu5]enkephalin-Thr and the nonselective opioids levorphanol, etorphine, and ethylketocyclazocine were found to desensitize δ receptors. [dPen2,d-Pen5]enkephalin, [d-Ser2,Leu5]enkephalin-Thr, [d-Ala2,d-Leu5]enkephalin, and etorphine treatments also caused a pronounced internalization of the epitope-tagged δ receptor, suggesting that the desensitization and internalization may be related. In contrast, levorphanol pretreatment did not internalize the receptor but still resulted in a 400-fold reduction in potency, suggesting that prolonged treatment with levorphanol only uncoupled the δ receptor from adenylyl cyclase. In contrast to the desensitization induced by peptide-selective δ agonists, pretreatment with the δ-selective nonpeptide agonist 7-spiroindanyloxymorphone and morphine sensitized the opioid inhibition of forskolin-stimulated cAMP accumulation. This differential regulation of the δ receptor may be due to variations in the ability of agonists to bind to the receptor. This hypothesis was supported by the finding that a point mutation that converted Asp128 to Asn128 (D128N) diminished the ability of δ-selective agonists to inhibit cAMP accumulation while increasing the potency of morphine to reduce cAMP accumulation. In particular, a lack of desensitization of the δ receptor by morphine may contribute to our understanding of the molecular basis of development of morphine-induced tolerance and dependence.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|